At medibles, we believe wellness should be personal, precise, and rooted in science. That’s why we’re initiating our own and closely tracking advances in cannabinoid research, primarily how compounds like CBD (cannabidiol) interact with the body and brain at the molecular level. A groundbreaking new study published in the Journal of Applied Genetics explores how […]
As public attitudes shift and sports leagues revisit cannabis policy, a powerful question is emerging across locker rooms, training facilities, and research labs alike: Can cannabinoids like CBD and THC help athletes train smarter, recover faster, and stay healthier? A new peer-reviewed paper titled “Cannabinoid Therapy in Athletics” (Thompson et al., 2024) suggests the answer
At medibles, we believe the future of medicine is precise and personalized. Today, we’re excited to share a significant step forward in that vision. Medibles, the personalized health and wellness platform developed by BIOMED Inc., is proud to announce our participation in the National Institutes of Health’s (NIH) All of Us Research Program. This partnership
Certain drugs interact with Cannabidiol; these interactions typically involve drugs metabolized by CYP450 enzymes and could possibly interact with CBD. LOS ANGELES, April 11, 2025 /PRNewswire/ — As the wellness industry evolves, more people are turning to Cannabidiol (CBD) for relief, recovery, and resilience. But as with any active compound, CBD does not exist in
Today, Los Angeles, February 10, 2023 /PRNewswire/ — BIOMED, medibles parent company and the leading next-generation healthcare platform, was chosen as one of the top ten finalists for the MedTech Color 2023 Pitch Competition. MedTech Color (MTC) is a nonprofit organization that aims to advance the representation of persons of color in the Medtech industry.
BIOMED, Chosen As A Top Ten Finalists For The MedTech Color 2023 Pitch Competition Read More »
Cannabis legalization has been an enormous success with a significant economic impact. The new report from this Federal Reserve Bank district shows how cannabis-related businesses create jobs and generate tax revenue. An analysis was published last week by the Federal Reserve bank of Kansas City, which covers the 10th District of the Federal Reserve, which includes
Cannabidiol (CBD) is a drug being studied for its ability to treat many psychiatric disorders. The current review looked at whether CBD could be used to treat anxiety-related disorders by assessing evidence from preclinical, human experimental, clinical, and epidemiological studies. The review found strong evidence that CBD can be used to treat panic disorder, social anxiety
Does CBD Help Relieve Stress and Social Anxiety Disorder? Read More »
The legalization of cannabis has had a significant effect on pharmaceutical companies. A new study research project titled “U.S. Cannabis Laws Projected to Cost Generic, and Brand Pharmaceutical Firms Billions” used CRSP US Stock North America Daily Update, a third-party dataset; found that, since 1996, when legalizations began in U.S states for both generic and brand-name drugs alike,
New Study, Pharmaceutical Companies Losing Billions After States Legalize Cannabis Read More »
For many of us, our pets are like family. So, when they’re not feeling well, we want to do everything we can to help them feel better. CBD oil has been shown to provide numerous health benefits in humans, so it’s only natural that pet parents wonder if it can help their furry friends, too.
Can CBD Help Your Pet? Here’s What You Need to Know Read More »
The data from two placebo-controlled, double-blind studies suggest that CBD seems to buffer against some acute effects on the brain with THC. According to study outcomes published in the Journal of Psychopharmacology, more significant strains containing more CBD may be less harmful. “One of the most interesting things we found was that some cannabinoids work better
New Research: Neuroimaging research shows the potential of CBD’s protective properties Read More »